Document Classification

Section Type: RESULTS

Text: After being treated with combination therapy for 2. 7 years in average, in the combination therapy group, the luteinizing hormone peak value of LHRH stimulating test was reduced from 48. 5 + / - 37. 1 IU/L to 12. 2 + / - 9. 3 IU/L (P < 0. 001), size of uterus and ovary decreased, secondary sexual characteristics regressed, the bone age difference/chronological age difference value (delta BA/delta CA) reduced from 1. 35 + / - 0. 64 to 0. 65 + / - 0. 36 (P < 0. 001), and predictive final height increased from 153. 3 + / - 3. 6 cm to 158. 5 + / - 4. 3 cm (P < 0. 001).